You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
McKesson
Dow
Boehringer Ingelheim
Baxter

Last Updated: November 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Genentech, Inc. v. Aurobindo Pharma Limited (D. Del. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Genentech, Inc. v. Aurobindo Pharma Limited (D. Del. 2019)

Docket   Start Trial Date Filed 2019-01-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties LUPIN LTD.; MACLEODS PHARMACEUTICALS LTD.
Patents 7,566,729; 7,635,707; 7,696,236; 7,767,225; 7,767,700; 7,816,383; 7,910,610; 7,988,994; 8,013,002; 8,084,475; 8,318,780; 8,383,150; 8,420,674; 8,592,462; 8,609,701; 8,648,098; 8,753,679; 8,754,109; 8,778,947
Attorneys Jonathan W.S. England; Timothy F. Peterson
Firms Phillips, Goldman, McLaughlin & Hall, P.A.; Phillips, McLaughlin & Hall, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Genentech, Inc. v. Aurobindo Pharma Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Genentech, Inc. v. Aurobindo Pharma Limited (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-10-20 226 Order - -Memorandum and Order single term in U.S. Patent Nos. 7,566,729 (“the ’729 patent”), 7,635,707 (“the ’707 patent”), and 8,592,462… construction for a single term in U.S. Patent Nos. 7,566,729, 7,635,707, and 8,592,462. Plaintiffs'…the ‘729 patent, claims 2, 8, and 10 of the ‘707 patent, and claims 18 and 23 of the ‘462 patent. (D.I. … “It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2019-01-13 4 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,225 B2; … 14 January 2019 1:19-cv-00078 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-12-16 81 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1 ;7,767,700… 14 January 2019 1:19-cv-00078 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKinsey
Baxter
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.